Drug Policy

The “war on drugs” in the US and similar restrictive drug policies worldwide have resulted in mass incarcerations for nonviolent drug offenses and an immense black market for illicit substances that further contributes to crime, violence, and corruption across the globe. And yet the demand for illegal drugs hasn’t waned but increased, and greater numbers of drug users are dying from overdoses than ever before. At this crossroad in understanding how drug policy should be constructed, many advocates have emerged to suggest an approach grounded in both science and compassion, changing the conversation about how to address the issue of illicit substances and the people who use them. We’ve started gathering valuable information on this topic, but haven’t yet curated the findings.

Why MDMA Must Be Reclassified as a Schedule 2 Drug

Amanda Feilding of the Beckley Foundation discusses the organisations new report ‘Roadmaps to Regulation: MDMA’ which recommends rescheduling MDMA to a Schedule 2 drug.

The New Year Is Prime Time for Unnecessary Drug-Related Deaths – Legalising MDMA Could Stop Them

As someone who’s been fighting for reform for over 20 years, I know a regulated market and a deeper understanding of substances would go a long way towards mitigating the risks.

5 Women in Psychedelics You Should Know About

Badass women making waves in the psychedelic movement, from research to drug policy reform.

The Interview: MDMA-Therapy Expert Dr. Rick Doblin

The world’s leading advocate for the medicinal use of psychedelics on the ghost of Timothy Leary, why Ecstasy could cure PTSD, and the best place to trip in Boston.


Psychedelic Research